Clinical Trial Update: Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients [Phase 2]

View source ↗

Summary

The document reports Phase 2 trial results evaluating tideglusib for mild-to-moderate Alzheimer's disease, focusing on efficacy, safety, and tolerability. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tideglusib (tideglusib)

Snippet

Sponsor: Noscira SA | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED